GlassScriptPhysician profile
Ashley S Baker
NPI 1396974382
$12,695.25
in general payments reported to CMS, 2019-2025
26 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,022 · 2020: $739 · 2021: $623 · 2022: $2,640 · 2023: $727 · 2024: $1,425 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Travel and Lodging: $919 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.62 |
| Travel and Lodging | $918.52 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $4,605.30 | 2019-2022 | |
| Medtronic, INC. | $3,709.82 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $1,603.32 | 2019-2020 | |
| Valencia Technologies Corporation | $1,004.85 | 2024 | Ecoin Device Kit |
| Coloplast Corp | $470.36 | 2023-2025 | Titan |
| Janssen Biotech, INC. | $306.27 | 2019-2023 | Erleada |
| Boston Scientific Corporation | $194.49 | 2019-2025 | General - Male Sui, Upsylon |
| Allergan, INC. | $193.15 | 2020-2022 | |
| Koelis INC. | $98.88 | 2025 | |
| Endo Pharmaceuticals INC. | $92.99 | 2022-2023 | Xiaflex, Aveed |
| 180 Medical, INC. | $62.57 | 2023 | Gentlecath Glide, Cure Catheter |
| Pfizer INC. | $62.56 | 2019 | |
| Abbvie INC. | $45.49 | 2019 | |
| Endo USA, INC. | $34.39 | 2024-2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $28.44 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $26.62 | 2023 | Axonics |
| Merck Sharp & Dohme LLC | $25.43 | 2023 | Lynparza, Welireg, Keytruda |
| Calyxo, INC. | $24.09 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $23.41 | 2019 | |
| Amgen INC. | $20.31 | 2020 | |
| Urovant Sciences INC | $17.57 | 2022 | |
| Travere Therapeutics, INC. | $16.11 | 2025 | Thiola |
| Cytyc Corporation | $14.72 | 2020 | |
| Urogen Pharma, INC. | $14.11 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.